COMMUNIQUÉS West-GlobeNewswire

Sanofi finalise l'acquisition de Bioverativ Inc.

08/03/2018 - 15:00

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Sanofi finalise l'acquisition de Bioverativ Inc. Bioverativ Inc. devient une filiale détenue à 100% par Sanofi Paris (France) - Le 8 mars 2018 - Sanofi [...]

First-time ACC Exhibitor Konica Minolta Healthcare to Showcase PACS Functionality for Cardiac Imaging

08/03/2018 - 15:00

WAYNE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., will introduce Exa™ Cardio to cardiologists as a first-time exhibitor at the American College of Cardiology (ACC) 67 th Annual [...]

Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock

08/03/2018 - 15:00

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq: CKPT ), a Fortress Biotech (Nasdaq: FBIO ) company, today announced the pricing of its previously [...]

Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi™ Epinephrine Prefilled Syringe to the Market Leading Product in the Annals of Allergy, Asthma and Immunology

08/03/2018 - 15:00

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Adamis”) today announced that a study titled “Human Factors Study in Untrained Adolescents Comparing Its Epinephrine [...]

MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2017 Results on March 15

08/03/2018 - 15:00

IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2017 fourth quarter and full year, which ended December 31, 2017, on [...]

Imaging3 Announces the Appointment of Joe Biehl as CFO

08/03/2018 - 15:00

BURBANK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Burbank, March 8, 2018: Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry is pleased to [...]

Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer

08/03/2018 - 14:59

Bavarian Nordic and Bristol-Myers Squibb agree to supply clinical material for the trial Investigator-led study represents the fourth clinical combination of CV301 with a checkpoint inhibitor COPENHAGEN, Denmark, March [...]

Galectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor Conference

08/03/2018 - 14:30

NORCROSS, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold Shlevin, the Company’s [...]

Agritek Holdings, Inc. Announces Purchase Order For First 10,000 Vaporizer Cartridges Under Company's MD VapeLine To California Licensed Facility

08/03/2018 - 14:30

LOS ANGELES, CA, March 08, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB:AGTK) ("the Company") ( www.AgritekHoldings.com ) a fully integrated, active cannabis real estate investor and branding consultant in the [...]

EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel

08/03/2018 - 14:30

WALTHAM, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]

MJ Biotech, Inc Financial Corporate Update

08/03/2018 - 14:25

CHEYENNE, Wyo., March 08, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) Zen’s Tea House, sales results for February 2018 were just over $138,000; combining that with the [...]

Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

08/03/2018 - 14:19

IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) announced the Mexico’s COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios - Mexico’s equivalent of the U.S. Food [...]

Organovo to Present at 30th Annual ROTH Conference

08/03/2018 - 14:05

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that Chief Financial Officer Craig Kussman is scheduled to speak at the 30 th Annual ROTH Conference in [...]

Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results Conference Call and Webcast on Thursday, March 15th, 2018

08/03/2018 - 14:04

CORAL GABLES, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]

Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018

08/03/2018 - 14:01

SAN CARLOS, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

Intra-Cellular Therapies to Present at the Cowen and Company 38th Annual Health Care Conference

08/03/2018 - 14:00

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]

Cidara Therapeutics to Present Rezafungin Data at the European Society for Blood and Marrow Transplantation 2018 Meeting

08/03/2018 - 14:00

SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that two rezafungin abstracts [...]

Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018

08/03/2018 - 14:00

REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Albireo to Report Fourth Quarter and Year-End 2017 Financial Results and Host Conference Call and Webcast on March 15, 2018

08/03/2018 - 14:00

BOSTON, March 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its fourth quarter and [...]